Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Samalin

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 11, 2024
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disordersMargot Chouchana, Clément Delage, Ophélia Godin, et al.
Journal of Affective Disorders|February 19, 2021
Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-upJulia-Lou Consoloni, Katia M'Bailara, Cyrille Perchec, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 31, 2017
Serotonin transporter gene expression predicts the worsening of suicidal ideation and suicide attempts along a long-term follow-up of a Major Depressive EpisodeJulia-Lou Consoloni, El Chérif Ibrahim, Marie-Noëlle Lefebvre, et al.
Journal of Affective Disorders|March 26, 2021
Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort<sup>✰</sup>Sébastien Brodeur, Hugo Terrisse, Arnaud Pouchon, et al.
Data in Brief|April 15, 2021
Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypesSébastien Brodeur, Hugo Terrisse, Arnaud Pouchon, et al.
Journal of Clinical Medicine|February 15, 2022
Self-Reported Pain and Emotional Reactivity in Bipolar Disorder: A Prospective FACE-BD StudyNathan Risch, Jonathan Dubois, Katia M'bailara, et al.
Journal of Affective Disorders|March 6, 2022
Direct medical cost of bipolar disorder: Insights from the FACE-BD longitudinal cohortCharles Laidi, Ophélia Godin, Bruno Etain, et al.
Translational Psychiatry|March 1, 2024
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1Luana Spano, Cynthia Marie-Claire, Ophélia Godin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 29, 2016
Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorderIsabella Pacchiarotti, Jordi León-Caballero, Andrea Murru, et al.
Journal of Affective Disorders|March 13, 2025
Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohortLudovic Samalin, Ophelia Godin, Xavier Moisset, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 11, 2024
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disordersMargot Chouchana, Clément Delage, Ophélia Godin, et al.
Journal of Affective Disorders|February 19, 2021
Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-upJulia-Lou Consoloni, Katia M'Bailara, Cyrille Perchec, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 31, 2017
Serotonin transporter gene expression predicts the worsening of suicidal ideation and suicide attempts along a long-term follow-up of a Major Depressive EpisodeJulia-Lou Consoloni, El Chérif Ibrahim, Marie-Noëlle Lefebvre, et al.
Journal of Affective Disorders|March 26, 2021
Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort<sup>✰</sup>Sébastien Brodeur, Hugo Terrisse, Arnaud Pouchon, et al.
Data in Brief|April 15, 2021
Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypesSébastien Brodeur, Hugo Terrisse, Arnaud Pouchon, et al.
Journal of Clinical Medicine|February 15, 2022
Self-Reported Pain and Emotional Reactivity in Bipolar Disorder: A Prospective FACE-BD StudyNathan Risch, Jonathan Dubois, Katia M'bailara, et al.
Journal of Affective Disorders|March 6, 2022
Direct medical cost of bipolar disorder: Insights from the FACE-BD longitudinal cohortCharles Laidi, Ophélia Godin, Bruno Etain, et al.
Translational Psychiatry|March 1, 2024
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1Luana Spano, Cynthia Marie-Claire, Ophélia Godin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 29, 2016
Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorderIsabella Pacchiarotti, Jordi León-Caballero, Andrea Murru, et al.
Journal of Affective Disorders|March 13, 2025
Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohortLudovic Samalin, Ophelia Godin, Xavier Moisset, et al.
Pageof 13